{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T12:53:56Z","timestamp":1776084836088,"version":"3.50.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Medical Innovation Research Project of Shanghai Science and Technology Commission","award":["22Y11901500"],"award-info":[{"award-number":["22Y11901500"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-026-04166-6","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T10:46:58Z","timestamp":1772707618000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Autophagy promotes the brain metastasis of cisplatin-resistant lung cancer cells through the KLF4\/KLF2\/IL15 signaling pathway"],"prefix":"10.1186","volume":"31","author":[{"given":"Yong","family":"Cai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wentao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,5]]},"reference":[{"key":"4166_CR1","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.intimp.2014.04.026","volume":"21","author":"G Zhang","year":"2014","unstructured":"Zhang G, Zhao H, Wu J, Li J, Xiang Y, Wang G, et al. Adoptive immunotherapy for non-small cell lung cancer by NK and cytotoxic T lymphocytes mixed effector cells: retrospective clinical observation. Int Immunopharmacol. 2014;21:396\u2013405.","journal-title":"Int Immunopharmacol"},{"key":"4166_CR2","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s40880-017-0219-2","volume":"36","author":"YJ Li","year":"2017","unstructured":"Li YJ, Lei YH, Yao N, Wang CR, Hu N, Ye WC, et al. Autophagy and multidrug resistance in cancer. Chin J Cancer. 2017;36:52.","journal-title":"Chin J Cancer"},{"issue":"Suppl 1","key":"4166_CR3","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.3816\/CLC.2002.s.001","volume":"3","author":"CP Belani","year":"2002","unstructured":"Belani CP. Chemotherapy regimens in advanced non-small-cell lung cancer: recent randomized trials. Clin Lung Cancer. 2002;3(Suppl 1):S5-9.","journal-title":"Clin Lung Cancer"},{"key":"4166_CR4","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/sj.cgt.7701120","volume":"15","author":"S Shamimi-Noori","year":"2008","unstructured":"Shamimi-Noori S, Yeow WS, Ziauddin MF, Xin H, Tran TL, Xie J, et al. Cisplatin enhances the antitumor effect of tumor necrosis factor-related apoptosis-inducing ligand gene therapy via recruitment of the mitochondria-dependent death signaling pathway. Cancer Gene Ther. 2008;15:356\u201370.","journal-title":"Cancer Gene Ther"},{"key":"4166_CR5","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1093\/neuonc\/nox077","volume":"19","author":"DN Cagney","year":"2017","unstructured":"Cagney DN, Martin AM, Catalano PJ, Redig AJ, Lin NU, Lee EQ, et al. Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study. Neuro-oncol. 2017;19:1511\u201321.","journal-title":"Neuro-oncol"},{"key":"4166_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21010254","author":"Y Nishiguchi","year":"2019","unstructured":"Nishiguchi Y, Oue N, Fujiwara-Tani R, Sasaki T, Ohmori H, Kishi S, et al. Role of metastasis-related genes in Cisplatin chemoresistance in gastric cancer. Int J Mol Sci. 2019. https:\/\/doi.org\/10.3390\/ijms21010254.","journal-title":"Int J Mol Sci"},{"key":"4166_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2020.612091","volume":"8","author":"M Xu","year":"2020","unstructured":"Xu M, Wang Y, Duan W, Xia S, Wei S, Liu W, et al. Proteomic reveals reasons for acquired drug resistance in lung cancer derived brain metastasis based on a newly established multi-organ microfluidic chip model. Front Bioeng Biotechnol. 2020;8:612091.","journal-title":"Front Bioeng Biotechnol"},{"key":"4166_CR8","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ccr.2006.06.001","volume":"10","author":"K Degenhardt","year":"2006","unstructured":"Degenhardt K, Mathew R, Beaudoin B, Bray K, Anderson D, Chen G, et al. Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell. 2006;10:51\u201364.","journal-title":"Cancer Cell"},{"key":"4166_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/srep12291","volume":"5","author":"HM Wu","year":"2015","unstructured":"Wu HM, Jiang ZF, Ding PS, Shao LJ, Liu RY. Hypoxia-induced autophagy mediates cisplatin resistance in lung cancer cells. Sci Rep. 2015;5:12291.","journal-title":"Sci Rep"},{"key":"4166_CR10","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.cardiores.2005.08.014","volume":"68","author":"A Terman","year":"2005","unstructured":"Terman A, Brunk UT. Autophagy in cardiac myocyte homeostasis, aging, and pathology. Cardiovasc Res. 2005;68:355\u201365.","journal-title":"Cardiovasc Res"},{"key":"4166_CR11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1146\/annurev.nutr.27.061406.093749","volume":"27","author":"N Mizushima","year":"2007","unstructured":"Mizushima N, Klionsky DJ. Protein turnover via autophagy: implications for metabolism. Annu Rev Nutr. 2007;27:19\u201340.","journal-title":"Annu Rev Nutr"},{"key":"4166_CR12","doi-asserted-by":"publisher","first-page":"2970","DOI":"10.1158\/0008-5472.CAN-11-3396","volume":"72","author":"WJ Buchser","year":"2012","unstructured":"Buchser WJ, Laskow TC, Pavlik PJ, Lin HM, Lotze MT. Cell-mediated autophagy promotes cancer cell survival. Cancer Res. 2012;72:2970\u20139.","journal-title":"Cancer Res"},{"key":"4166_CR13","volume":"8","author":"J Wang","year":"2022","unstructured":"Wang J, Dong Z, Sheng Z, Cai Y. Hypoxia-induced PVT1 promotes lung cancer chemoresistance to cisplatin by autophagy via PVT1\/miR-140-3p\/ATG5 axis. Cell Death Discov. 2022;8:104.","journal-title":"Cell Death Discov"},{"key":"4166_CR14","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1136\/thoraxjnl-2021-217001","volume":"77","author":"G Leem","year":"2022","unstructured":"Leem G, Jeon M, Kim KW, Jeong S, Choi SJ, Lee YJ, et al. Tumour-infiltrating bystander CD8(+) T cells activated by IL-15 contribute to tumour control in non-small cell lung cancer. Thorax. 2022;77:769\u201380.","journal-title":"Thorax"},{"key":"4166_CR15","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-004104","author":"JA Hangasky","year":"2022","unstructured":"Hangasky JA, Chen W, Dubois SP, Daenthanasanmak A, M\u00fcller JR, Reid R, et al. A very long-acting IL-15: implications for the immunotherapy of cancer. J Immunother Cancer. 2022. https:\/\/doi.org\/10.1136\/jitc-2021-004104.","journal-title":"J Immunother Cancer"},{"key":"4166_CR16","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1038\/s41590-019-0405-2","volume":"20","author":"X Zhou","year":"2019","unstructured":"Zhou X, Yu J, Cheng X, Zhao B, Manyam GC, Zhang L, et al. The deubiquitinase Otub1 controls the activation of CD8(+) T cells and NK cells by regulating IL-15-mediated priming. Nat Immunol. 2019;20:879\u201389.","journal-title":"Nat Immunol"},{"key":"4166_CR17","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-006683","author":"A Battistoni","year":"2023","unstructured":"Battistoni A, Lantier L, di Tommaso A, Ducournau C, Lajoie L, Samimi M, et al. Nasal administration of recombinant Neospora caninum secreting IL-15\/IL-15R\u03b1 inhibits metastatic melanoma development in lung. J Immunother Cancer. 2023. https:\/\/doi.org\/10.1136\/jitc-2023-006683.","journal-title":"J Immunother Cancer"},{"key":"4166_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114661","volume":"162","author":"ZY Li","year":"2023","unstructured":"Li ZY, Zhu YX, Chen JR, Chang X, Xie ZZ. The role of KLF transcription factor in the regulation of cancer progression. Biomed Pharmacother. 2023;162:114661.","journal-title":"Biomed Pharmacother"},{"key":"4166_CR19","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jhep.2016.07.051","volume":"66","author":"S Guix\u00e9-Muntet","year":"2017","unstructured":"Guix\u00e9-Muntet S, de Mesquita FC, Vila S, Hern\u00e1ndez-Gea V, Peralta C, Garc\u00eda-Pag\u00e1n JC, et al. Cross-talk between autophagy and KLF2 determines endothelial cell phenotype and microvascular function in acute liver injury. J Hepatol. 2017;66:86\u201394.","journal-title":"J Hepatol"},{"key":"4166_CR20","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1084\/jem.20031132","volume":"199","author":"S SenBanerjee","year":"2004","unstructured":"SenBanerjee S, Lin Z, Atkins GB, Greif DM, Rao RM, Kumar A, et al. KLF2 is a novel transcriptional regulator of endothelial proinflammatory activation. J Exp Med. 2004;199:1305\u201315.","journal-title":"J Exp Med"},{"key":"4166_CR21","volume":"3","author":"AN Orekhov","year":"2019","unstructured":"Orekhov AN, Orekhova VA, Nikiforov NG, Myasoedova VA, Grechko AV, Romanenko EB, et al. Monocyte differentiation and macrophage polarization. Vessel Plus. 2019;3:2574-1209.2019.","journal-title":"Vessel Plus"},{"key":"4166_CR22","doi-asserted-by":"publisher","first-page":"38247","DOI":"10.1074\/jbc.M509378200","volume":"280","author":"MW Feinberg","year":"2005","unstructured":"Feinberg MW, Cao Z, Wara AK, Lebedeva MA, SenBanerjee S, Jain MK. Kruppel-like factor 4 is a mediator of proinflammatory signaling in macrophages *. J Biol Chem. 2005;280:38247\u201358.","journal-title":"J Biol Chem"},{"key":"4166_CR23","doi-asserted-by":"publisher","first-page":"7338","DOI":"10.1128\/JVI.74.16.7338-7348.2000","volume":"74","author":"N Azimi","year":"2000","unstructured":"Azimi N, Shiramizu KM, Tagaya Y, Mariner J, Waldmann TA. Viral activation of interleukin-15 (IL-15): characterization of a virus-inducible element in the IL-15 promoter region. J Virol. 2000;74:7338\u201348.","journal-title":"J Virol"},{"key":"4166_CR24","first-page":"35","volume":"2","author":"PA Andrews","year":"1990","unstructured":"Andrews PA, Howell SB. Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistance. Cancer Cells. 1990;2:35\u201343.","journal-title":"Cancer Cells"},{"key":"4166_CR25","first-page":"573","volume":"2","author":"S Kasibhatla","year":"2003","unstructured":"Kasibhatla S, Tseng B. Why target apoptosis in cancer treatment? Mol Cancer Ther. 2003;2:573\u201380.","journal-title":"Mol Cancer Ther"},{"key":"4166_CR26","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1080\/15548627.2017.1360466","volume":"13","author":"N Kaverina","year":"2017","unstructured":"Kaverina N, Borovjagin AV, Kadagidze Z, Baryshnikov A, Baryshnikova M, Malin D, et al. Astrocytes promote progression of breast cancer metastases to the brain via a KISS1-mediated autophagy. Autophagy. 2017;13:1905\u201323.","journal-title":"Autophagy"},{"key":"4166_CR27","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s11060-018-2959-5","volume":"140","author":"N Hashemi-Sadraei","year":"2018","unstructured":"Hashemi-Sadraei N, M\u00fcller-Greven GM, Abdul-Karim FW, Ulasov I, Downs-Kelly E, Burgett ME, et al. Expression of LC3B and FIP200\/Atg17 in brain metastases of breast cancer. J Neurooncol. 2018;140:237\u201348.","journal-title":"J Neurooncol"},{"key":"4166_CR28","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1093\/neuonc\/noz198","volume":"22","author":"N Santana-Codina","year":"2020","unstructured":"Santana-Codina N, Muix\u00ed L, Foj R, Sanz-Pamplona R, Badia-Villanueva M, Abramowicz A, et al. GRP94 promotes brain metastasis by engaging pro-survival autophagy. Neuro-oncol. 2020;22:652\u201364.","journal-title":"Neuro-oncol"},{"key":"4166_CR29","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s10585-023-10202-0","volume":"40","author":"H Xi","year":"2023","unstructured":"Xi H, Wu M, Ma H, Li S, Huang Q, Zhang Y, et al. Repurposing fluphenazine to suppress melanoma brain, lung and bone metastasis by inducing G0\/G1 cell cycle arrest and apoptosis and disrupting autophagic flux. Clin Exp Metastasis. 2023;40:161\u201375.","journal-title":"Clin Exp Metastasis"},{"key":"4166_CR30","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.molonc.2014.05.009","volume":"8","author":"J Seoane","year":"2014","unstructured":"Seoane J, De Mattos-Arruda L. Brain metastasis: new opportunities to tackle therapeutic resistance. Mol Oncol. 2014;8:1120\u201331.","journal-title":"Mol Oncol"},{"key":"4166_CR31","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/sj.bjc.6605467","volume":"102","author":"D Johansson","year":"2010","unstructured":"Johansson D, Andersson C, Moharer J, Johansson A, Behnam-Motlagh P. Cisplatin-induced expression of Gb3 enables Verotoxin-1 treatment of cisplatin resistance in malignant pleural mesothelioma cells. Br J Cancer. 2010;102:383\u201391.","journal-title":"Br J Cancer"},{"key":"4166_CR32","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1097\/COC.0b013e3181ec5f4b","volume":"34","author":"K Matsuo","year":"2011","unstructured":"Matsuo K, Eno ML, Ahn EH, Shahzad MMK, Im DD, Rosenshein NB, et al. Multidrug resistance gene (MDR-1) and risk of brain metastasis in Epithelial Ovarian, Fallopian Tube, and Peritoneal Cancer. Am J Clin Oncol. 2011;34:488\u201393.","journal-title":"Am J Clin Oncol"},{"key":"4166_CR33","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1084\/jem.191.5.771","volume":"191","author":"MK Kennedy","year":"2000","unstructured":"Kennedy MK, Glaccum M, Brown SN, Butz EA, Viney JL, Embers M, et al. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J Exp Med. 2000;191:771\u201380.","journal-title":"J Exp Med"},{"key":"4166_CR34","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1182\/blood.V97.1.14","volume":"97","author":"TA Fehniger","year":"2001","unstructured":"Fehniger TA, Caligiuri MA. Interleukin 15: biology and relevance to human disease. Blood. 2001;97:14\u201332.","journal-title":"Blood"},{"key":"4166_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-019-0652-7","volume":"7","author":"YH Choi","year":"2019","unstructured":"Choi YH, Lim EJ, Kim SW, Moon YW, Park KS, An HJ. IL-27 enhances IL-15\/IL-18-mediated activation of human natural killer cells. J Immunother Cancer. 2019;7:168.","journal-title":"J Immunother Cancer"},{"key":"4166_CR36","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1038\/ni1487","volume":"8","author":"ND Huntington","year":"2007","unstructured":"Huntington ND, Puthalakath H, Gunn P, Naik E, Michalak EM, Smyth MJ, et al. Interleukin 15-mediated survival of natural killer cells is determined by interactions among Bim, Noxa and Mcl-1. Nat Immunol. 2007;8:856\u201363.","journal-title":"Nat Immunol"},{"key":"4166_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25215216","author":"JW Choi","year":"2020","unstructured":"Choi JW, Lim S, Kang JH, Hwang SH, Hwang KC, Kim SW, et al. Proteome analysis of human natural killer cell derived extracellular vesicles for identification of anticancer effectors. Molecules. 2020. https:\/\/doi.org\/10.3390\/molecules25215216.","journal-title":"Molecules"},{"key":"4166_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00364","volume":"6","author":"S Sonar","year":"2015","unstructured":"Sonar S, Lal G. Role of tumor necrosis factor superfamily in neuroinflammation and autoimmunity. Front Immunol. 2015;6:364.","journal-title":"Front Immunol"},{"key":"4166_CR39","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/s41590-023-01475-4","volume":"24","author":"MD Park","year":"2023","unstructured":"Park MD, Reyes-Torres I, LeBerichel J, Hamon P, LaMarche NM, Hegde S, et al. TREM2 macrophages drive NK cell paucity and dysfunction in lung cancer. Nat Immunol. 2023;24:792\u2013801.","journal-title":"Nat Immunol"},{"key":"4166_CR40","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/nrc928","volume":"2","author":"MJ Smyth","year":"2002","unstructured":"Smyth MJ, Hayakawa Y, Takeda K, Yagita H. New aspects of natural-killer-cell surveillance and therapy of cancer. Nat Rev Cancer. 2002;2:850\u201361.","journal-title":"Nat Rev Cancer"},{"key":"4166_CR41","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nri2073","volume":"7","author":"HG Ljunggren","year":"2007","unstructured":"Ljunggren HG, Malmberg KJ. Prospects for the use of NK cells in immunotherapy of human cancer. Nat Rev Immunol. 2007;7:329\u201339.","journal-title":"Nat Rev Immunol"},{"key":"4166_CR42","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1385\/IR:36:1:13","volume":"36","author":"Q Yang","year":"2006","unstructured":"Yang Q, Goding SR, Hokland ME, Basse PH. Antitumor activity of NK cells. Immunol Res. 2006;36:13\u201325.","journal-title":"Immunol Res"},{"key":"4166_CR43","doi-asserted-by":"publisher","first-page":"6488","DOI":"10.1073\/pnas.1221312110","volume":"110","author":"PJ Choi","year":"2013","unstructured":"Choi PJ, Mitchison TJ. Imaging burst kinetics and spatial coordination during serial killing by single natural killer cells. Proc Natl Acad Sci USA. 2013;110:6488\u201393.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4166_CR44","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/leu.2013.188","volume":"28","author":"B Vogel","year":"2014","unstructured":"Vogel B, Tennert K, Full F, Ensser A. Efficient generation of human natural killer cell lines by viral transformation. Leukemia. 2014;28:192\u20135.","journal-title":"Leukemia"},{"key":"4166_CR45","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-024-01576-y","volume":"15","author":"W Zhou","year":"2024","unstructured":"Zhou W, Huang H, Teng Y, Hua R, Hu Y, Li X. KLF4 promotes cisplatin resistance by activating mTORC1 signaling in ovarian cancer. Discover oncology. 2024;15:682.","journal-title":"Discover oncology"},{"key":"4166_CR46","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.3384","volume":"23","author":"Z Tuo","year":"2021","unstructured":"Tuo Z, Liang L, Zhou R. LINC00852 is associated with poor prognosis in non-small cell lung cancer patients and its inhibition suppresses cancer cell proliferation and chemoresistance via the hsa-miR-145-5p\/KLF4 axis. J Gene Med. 2021;23:e3384.","journal-title":"J Gene Med"},{"key":"4166_CR47","doi-asserted-by":"publisher","first-page":"7772","DOI":"10.1128\/MCB.00468-06","volume":"26","author":"Y Nakatake","year":"2006","unstructured":"Nakatake Y, Fukui N, Iwamatsu Y, Masui S, Takahashi K, Yagi R, et al. Klf4 cooperates with Oct3\/4 and Sox2 to activate the Lefty1 core promoter in embryonic stem cells. Mol Cell Biol. 2006;26:7772\u201382.","journal-title":"Mol Cell Biol"},{"key":"4166_CR48","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1158\/0008-5472.CAN-12-2037","volume":"73","author":"H Okuda","year":"2013","unstructured":"Okuda H, Xing F, Pandey PR, Sharma S, Watabe M, Pai SK, et al. miR-7 suppresses brain metastasis of breast cancer stem-like cells by modulating KLF4. Cancer Res. 2013;73:1434\u201344.","journal-title":"Cancer Res"},{"key":"4166_CR49","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1038\/onc.2010.591","volume":"30","author":"F Yu","year":"2011","unstructured":"Yu F, Li J, Chen H, Fu J, Ray S, Huang S, et al. Kruppel-like factor 4 (KLF4) is required for maintenance of breast cancer stem cells and for cell migration and invasion. Oncogene. 2011;30:2161\u201372.","journal-title":"Oncogene"},{"key":"4166_CR50","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1080\/15384047.2021.1949228","volume":"22","author":"R Li","year":"2021","unstructured":"Li R, Chen J, Gao X, Jiang G. Transcription factor KLF2 enhances the sensitivity of breast cancer cells to cisplatin by suppressing kinase WEE1. Cancer Biol Ther. 2021;22:465\u201377.","journal-title":"Cancer Biol Ther"},{"key":"4166_CR51","first-page":"2024","volume":"9","author":"W Jiang","year":"2017","unstructured":"Jiang W, Xu X, Deng S, Luo J, Xu H, Wang C, et al. Methylation of Kruppel-like factor 2 (KLF2) associates with its expression and non-small cell lung cancer progression. Am J Transl Res. 2017;9:2024.","journal-title":"Am J Transl Res"},{"key":"4166_CR52","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1111\/jphp.13252","volume":"72","author":"S Xiao","year":"2020","unstructured":"Xiao S, Jin-Xiang Y, Long T, Xiu-Rong L, Hong G, Jie-Cheng Y, et al. Kruppel-like factor 2 disturb non-small cell lung cancer energy metabolism by inhibited glutamine consumption. J Pharm Pharmacol. 2020;72:843\u201351.","journal-title":"J Pharm Pharmacol"},{"key":"4166_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07810-w","volume":"9","author":"Z Zeng","year":"2018","unstructured":"Zeng Z, Li Y, Pan Y, Lan X, Song F, Sun J, et al. Cancer-derived exosomal miR-25-3p promotes pre-metastatic niche formation by inducing vascular permeability and angiogenesis. Nat Commun. 2018;9:5395.","journal-title":"Nat Commun"},{"key":"4166_CR54","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrc1780","volume":"6","author":"BD Rowland","year":"2006","unstructured":"Rowland BD, Peeper DS. KLF4, p21 and context-dependent opposing forces in cancer. Nat Rev Cancer. 2006;6:11\u201323.","journal-title":"Nat Rev Cancer"},{"key":"4166_CR55","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1038\/ncb1314","volume":"7","author":"BD Rowland","year":"2005","unstructured":"Rowland BD, Bernards R, Peeper DS. The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene. Nat Cell Biol. 2005;7:1074\u201382.","journal-title":"Nat Cell Biol"},{"key":"4166_CR56","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.1093\/nar\/28.15.2969","volume":"28","author":"JL Shie","year":"2000","unstructured":"Shie JL, Chen ZY, Fu M, Pestell RG, Tseng CC. Gut-enriched Kr\u00fcppel-like factor represses cyclin D1 promoter activity through Sp1 motif. Nucleic Acids Res. 2000;28:2969\u201376.","journal-title":"Nucleic Acids Res"},{"key":"4166_CR57","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18112383","author":"P Jha","year":"2017","unstructured":"Jha P, Das H. KLF2 in regulation of NF-\u03baB-mediated immune cell function and inflammation. Int J Mol Sci. 2017. https:\/\/doi.org\/10.3390\/ijms18112383.","journal-title":"Int J Mol Sci"},{"key":"4166_CR58","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1089\/hum.2009.187","volume":"21","author":"CM Chang","year":"2010","unstructured":"Chang CM, Lo CH, Shih YM, Chen Y, Wu PY, Tsuneyama K, et al. Treatment of hepatocellular carcinoma with adeno-associated virus encoding interleukin-15 superagonist. Hum Gene Ther. 2010;21:611\u201321.","journal-title":"Hum Gene Ther"},{"key":"4166_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-44789-z","volume":"15","author":"I Dean","year":"2024","unstructured":"Dean I, Lee CYC, Tuong ZK, Li Z, Tibbitt CA, Willis C, et al. Rapid functional impairment of natural killer cells following tumor entry limits anti-tumor immunity. Nat Commun. 2024;15:683.","journal-title":"Nat Commun"},{"key":"4166_CR60","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1126\/science.1068440","volume":"295","author":"L Ruggeri","year":"2002","unstructured":"Ruggeri L, Capanni M, Urbani E, Perruccio K, Shlomchik WD, Tosti A, et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science. 2002;295:2097\u2013100.","journal-title":"Science"},{"key":"4166_CR61","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1182\/blood-2004-07-2974","volume":"105","author":"JS Miller","year":"2005","unstructured":"Miller JS, Soignier Y, Panoskaltsis-Mortari A, McNearney SA, Yun GH, Fautsch SK, et al. Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer. Blood. 2005;105:3051\u20137.","journal-title":"Blood"},{"key":"4166_CR62","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0065-230X(03)90004-2","volume":"90","author":"J Wu","year":"2003","unstructured":"Wu J, Lanier LL. Natural killer cells and cancer. Adv Cancer Res. 2003;90:127\u201356.","journal-title":"Adv Cancer Res"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-026-04166-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-026-04166-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-026-04166-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T12:03:51Z","timestamp":1776081831000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40001-026-04166-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,5]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4166"],"URL":"https:\/\/doi.org\/10.1186\/s40001-026-04166-6","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,5]]},"assertion":[{"value":"8 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were approved by the Animal Ethics Committee of Tongji University School of Medicine.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"538"}}